[Current status of antiparkinson therapy].
D000547:Amantadine / Q000008:administration & dosage; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001545:Benserazide / Q000008:administration & dosage; D002230:Carbidopa / Q000008:administration & dosage; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage; D010300:Parkinson Disease / Q000188:drug therapy*; D011433:Propranolol / Q000008:administration & dosage
D000978:Antiparkinson Agents; D008996:Monoamine Oxidase Inhibitors; D007980:Levodopa; D001545:Benserazide; D011433:Propranolol; D000547:Amantadine; D002262:Carboxy-Lyases; D002230:Carbidopa
Stadiul actual al terapiei antiparkinsoniene